Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home
health, hospice, personal care and high-acuity care, has closed on
its joint venture with the University of Arkansas for Medical
Sciences (UAMS) to provide home health services in Searcy and
Little Rock.
This joint venture is part of the partnership between UAMS,
Amedisys and Contessa, an Amedisys company, to offer patients a
full spectrum of medical care in the comfort and convenience of
their own homes through UAMS Health Comprehensive Care at Home.
Clinical services will include Recovery Care at Home,
Rehabilitation Care at Home, Palliative Care at Home, Primary Care
at Home and Home Health.
Home health services include skilled nursing care; physical,
occupational and speech therapy; medical social work; and home
health aides to assist with activities of daily living, such as
bathing, dressing and eating. Home health services will operate as
UAMS Health Home Health across 12 counties in Central Arkansas.
“Amedisys is proud to partner with UAMS to provide a
comprehensive program that will improve the outcomes and
experiences for our patients in Central Arkansas,” stated Amedisys
Chairman and CEO Paul Kusserow. “Along with Contessa, our
partnership allows us to offer the first-of-its-kind model to the
region and the first Comprehensive Care at Home program to the
state. This also marks the first partnership where Amedisys and
Contessa are delivering this integrated model of comprehensive care
in the home from the outset - a model we look to provide with other
innovative health system partners nationwide.”
“UAMS is leading the ambitious goal of making Arkansas the
healthiest state in the region, and this strategic initiative
supercharges that vision,” said Cam Patterson, M.D., MBA, UAMS
chancellor and CEO of UAMS Health. “We are thrilled to partner with
Contessa and Amedisys to bring this first-of-its-kind model to the
region and the first Comprehensive Care at Home program to the
state. We look forward to giving our patients an innovative option
that delivers on our commitment of community-focused,
patient-centered care.”
Amedisys’ home health operations now include 353 care centers in
35 states, with an average daily census of approximately 70,000
patients and approximately 11,000 home health employees.
In 2022, Modern Healthcare named Amedisys, Inc. to its
prestigious Best Places to Work in Healthcare list for the second
consecutive year. Amedisys is the second largest provider of home
health care and the third largest provider of hospice care in the
United States. As of the October 2022 Home Health Compare release,
Amedisys’ Quality of Patient Care (QPC) Star score is 4.44. The
Company also provides hospice care, personal care, palliative care
and high-acuity care.
About UAMS UAMS is Arkansas’ only health
sciences university, with colleges of Medicine, Nursing, Pharmacy,
Health Professions and Public Health; a graduate school; a
hospital; a main campus in Little Rock; a Northwest Arkansas
regional campus in Fayetteville; a statewide network of regional
campuses; and seven institutes: the Winthrop P. Rockefeller Cancer
Institute, Jackson T. Stephens Spine & Neurosciences Institute,
Harvey & Bernice Jones Eye Institute, Psychiatric Research
Institute, Donald W. Reynolds Institute on Aging, Translational
Research Institute and Institute for Digital Health &
Innovation. UAMS includes UAMS Health, a statewide health system
that encompasses all of UAMS' clinical enterprise. UAMS is the only
adult Level 1 trauma center in the state. UAMS has 3,047 students,
873 medical residents and fellows, and six dental residents. It is
the state's largest public employer with more than 11,000
employees, including 1,200 physicians who provide care to patients
at UAMS, its regional campuses, Arkansas Children's, the VA Medical
Center and Baptist Health.
Visit www.uams.edu or uamshealth.com.
About Contessa Contessa, an Amedisys
company, delivers comprehensive care at home. An industry pioneer
since 2015, Contessa provides a coordinated suite of services
including Recovery Care at Home, in lieu of being admitted to a
hospital, Rehabilitation Care at Home, in lieu of being admitted to
a skilled nursing facility, and Palliative Care at Home. Combining
all the essential elements of an inpatient hospital or
rehabilitation stay into the comfort of patient’ homes, Contessa
allows partners to reimagine care delivery. Contessa utilizes Care
Convergence™, a proprietary technology platform, to power a
seamless solution that is safe, affordable and improves patient
outcomes.
Based in Nashville, the company currently partners with 12
health systems and 30 health plans serving patients in nine states.
Alongside Amedisys’s 21,000+ employees in 37 states, the company
has the ability to serve more patients in a full care continuum,
from primary care to end-of-life, all in the comfort of
home. For more information,
visit contessahealth.com or follow us at
@contessahealth.
About Amedisys Amedisys, Inc. is a leading
healthcare at home Company delivering personalized home health,
hospice, personal care and high-acuity care services. Amedisys is
focused on delivering the care that is best for our patients,
whether that is home-based personal care; inpatient hospital,
palliative, and skilled nursing facility (“SNF”) care in their
homes; recovery and rehabilitation after an operation or injury;
care focused on empowering them to manage a chronic disease; or
hospice care at the end of life. More than 3,000 hospitals and
90,000 physicians nationwide have chosen Amedisys as a partner in
post-acute care. Founded in 1982, headquartered in Baton Rouge, LA
with an executive office in Nashville, TN, Amedisys is a publicly
held company. With approximately 21,000 employees, in 547 care
centers in 37 states, Amedisys is dedicated to delivering the
highest quality of care to the doorsteps of more than 445,000
patients in need every year, performing more than 11.5 million
visits annually. For more information about the Company, please
visit: www.amedisys.com.
Forward-Looking Statements:
Words like “believes,” “belief,” “expects,” “strategy,” “plans,”
“anticipates,” “intends,” “projects,” “estimates,” “may,” “might,”
“will,” “could,” “would,” “should” and similar expressions are
intended to identify forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements involve a variety of risks and
uncertainties that could cause actual results to differ materially
from those described therein. These risks and uncertainties
include, but are not limited to the following: the impact of the
novel coronavirus pandemic (“COVID-19”), including the measures
that have been and may be taken by governmental authorities to
mitigate it, on our business, financial condition and results of
operations; the impact of current and proposed federal, state and
local vaccine mandates; staffing shortages driven by the
competitive labor markets; changes in or our failure to comply with
existing federal and state laws or regulations or the inability to
comply with new government regulations on a timely basis; changes
in Medicare and other medical payment levels; our ability to open
care centers, acquire additional care centers and integrate and
operate these care centers effectively; competition in the
healthcare industry; changes in the case mix of patients, the
episodic versus non-episodic mix of our payors and payment
methodologies; changes in estimates and judgments associated with
critical accounting policies; our ability to maintain or establish
new patient referral sources; our ability to consistently provide
high-quality care; our ability to attract and retain qualified
personnel; our ability to keep our patients and employees safe;
changes in payments and covered services by federal and state
governments; future cost containment initiatives undertaken by
third-party payors; our access to financing; our ability to meet
debt service requirements and comply with covenants in debt
agreements; business disruptions due to natural disasters, climate
change or acts of terrorism, widespread protests or civil unrest;
our ability to integrate, manage and keep our information systems
secure; the impact of inflation; our ability to realize the
anticipated benefits of acquisitions, investments and joint
ventures; and changes in laws or developments with respect to any
litigation relating to the Company, including various other
matters, many of which are beyond our control.
Contact:Nick MuscatoAmedisys, Inc.Investor
Relations615.928.5452nick.muscato@amedisys.com |
Kendra
KimmonsAmedisys, Inc.Media
Relations225.299.3720Kendra.kimmons@amedisys.com |
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2024 to May 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From May 2023 to May 2024